Detection of glucocorticoid receptor (GR) expression in circulating tumor cells (CTCs) from patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).

被引：0
|
作者：
Wise, David
Louw, Jessica
Krupa, Rachel
Schreiber, Nicole A.
Sawyers, Charles L.
Dittamore, Ryan Vance
Scher, Howard I.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.5046
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5046
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Glucocorticoid receptor (GR) expression in circulating tumor cells (CTCs) to prognosticate overall survival (OS) for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with androgen receptor signaling inhibitors (ARSi).
    Wise, David
    Kelvin, James
    Graf, Ryon
    Schreiber, Nicole A.
    McLaughlin, Brigit
    Fernandez, Luisa
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [2] CD133 expression in circulating tumor cells (CTCs) from metastatic castration-resistant prostate cancer (mCRPC).
    Ana Marcos, Rosa
    Alfonso, Sara
    Lozano, Rebeca
    Matos, Ignacio
    Espinet, Blanca
    Garcia, Rocio
    Maria Hernandez, Jesus
    Gomez-Veiga, Francisco
    Luis Hernandez, Juan
    Cruz, Juan J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Detection and Genomic Interrogation of Circulating Tumor Cells (CTCs) and Circulating Tumor Stem Cells (CTSCs) From Men with Metastatic Castration-resistant Prostate Cancer (mCRPC)
    Friedlander, T.
    Ngo, V.
    Doty, S.
    Zhao, Q.
    Dong, H.
    Ryan, C.
    Chen, W.
    Paris, P.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 152 - 152
  • [4] Detection and genomic interrogation of circulating tumor cells (CTCs) and circulating tumor stem cells (CTSCs) from men with metastatic castration-resistant prostate cancer (mCRPC)
    Friedlander, Terence W.
    Vy Ngo
    Doty, Shaun
    Zhao, Qiang
    Dong, Huang
    Ryan, Charles J.
    Chen, Wen-Tien
    Paris, Pamela
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [5] Circulating tumor cells in patients with castration-resistant metastatic prostate cancer
    Danila, D. C.
    Leversha, M. A.
    Gonzalez-Espinoza, R.
    Anand, A.
    Gu, B.
    Gignac, G. A.
    Larson, S.
    Heller, G.
    Fleisher, M.
    Scher, H. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer
    Rini, Brian I.
    CURRENT ONCOLOGY REPORTS, 2009, 11 (03) : 163 - 164
  • [7] MOLECULAR PROFILING OF PERIPHERAL BLOOD IS ASSOCIATED WITH CIRCULATING TUMOR CELLS (CTCS) CONTENT AND SURVIVAL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC)
    Gaba Garcia, L.
    Marin-Aguilera, M.
    Lozano, J. J.
    Tagliapietra, A.
    Ortega, V.
    Gascon, P.
    Mellado, B.
    ANNALS OF ONCOLOGY, 2012, 23 : 300 - 300
  • [8] Circulating tumor cells in metastatic castration-resistant prostate cancer
    Brian I. Rini
    Current Oncology Reports, 2009, 11 : 163 - 164
  • [9] Molecular characterization of heterogeneity in circulating tumor cells (CTCs) and tumor samples of metastatic castration-resistant prostate cancer (mCRPC) patients: The multicenter PETRUS program.
    Massard, Christophe
    Oulhen, Marianne
    Le Moulec, Sylvestre
    Loriot, Yohann
    Auger, Nathalie
    Beuzeboc, Philippe
    Albiges, Laurence
    Culine, Stephane
    Oudard, Stephane
    Hennequin, Christophe
    Vielh, Philippe
    Farace, Francoise
    Fizazi, Karim
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [10] Single cell phenogenomic subtyping of circulating tumor cells (CTCs) identify intercellular tumor heterogeneity (het) and multiple resistance mechansisms in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
    Scher, Howard I.
    Graf, Ryon
    Jendrisak, Adam
    Schreiber, Nicole A.
    McLaughlin, Brigit
    Greene, Stephanie
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
12345